Reported 1 day ago
January tends to be a favorable month for stock performance, but long-term investors focus on solid companies for sustained growth. DexCom, a leader in continuous glucose monitoring devices, presents a strong investment opportunity due to its growth potential and expanding market reach. Exact Sciences, known for its innovative cancer diagnostic tests like Cologuard, is also positioned for future revenue growth, especially following FDA approval of an improved test. Both stocks are good picks for healthcare investors looking for promising opportunities.
Source: YAHOO